Immunophenotypic characteristics of NLPHL and cHL.
| . | NLPHL . | cHL . |
|---|---|---|
| Modifed from DeVita et al. Cancer. Principles & Practice of Oncology. Lippincott Williams & Wilkins; 2000. | ||
| Abbreviations: NLPHL, nodular lymphocyte-predominant Hodgkin lymphoma; cHL, classical Hodgkin lymphoma | ||
| CD15 | − | + |
| CD30 | − | + |
| CD20 | + | +/− |
| CD45 | + | − |
| EMA | + | − |
| CD57+ T cells | + | − |
| . | NLPHL . | cHL . |
|---|---|---|
| Modifed from DeVita et al. Cancer. Principles & Practice of Oncology. Lippincott Williams & Wilkins; 2000. | ||
| Abbreviations: NLPHL, nodular lymphocyte-predominant Hodgkin lymphoma; cHL, classical Hodgkin lymphoma | ||
| CD15 | − | + |
| CD30 | − | + |
| CD20 | + | +/− |
| CD45 | + | − |
| EMA | + | − |
| CD57+ T cells | + | − |